Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.58
Peer-review started: August 6, 2015
First decision: September 16, 2015
Revised: October 27, 2015
Accepted: December 13, 2015
Article in press: December 15, 2015
Published online: February 10, 2016
Processing time: 183 Days and 14.3 Hours
Core tip: Invasive testing remains the only way to provide comprehensive testing for chromosomal abnormalities. Despite availability of cell free fetal DNA testing, amniocentesis should still be offered to all women who desire complete genetic testing. Amniocentesis is also useful if intraamniotic infection is suspected, but the clinical picture is unclear. Additionally, when late preterm delivery is indicated, amniocentesis need not be used. There are, however, some instances when delivery timing is unclear and amniocentesis for fetal lung maturity may provide information to guide delivery timing. Amniocentesis is a relatively safe procedure. We counsel patients that technique has changed since the original studies in the 1970s and feel comfortable quoting a loss rate of 1/500-1/1000 based on contemporary data.
